Artificial Intelligence Predicts Gestational Diabetes in Chinese Women

Machine learning, a form of artificial intelligence, can predict which women are at high risk of developing gestational diabetes and lead to earlier intervention, according to a new study.

Gestational diabetes is a common complication during pregnancy that affects up to 15% of pregnant women. High blood sugar in the mother can be dangerous for the baby and lead to complications like stillbirth and premature delivery. Most women are diagnosed with gestational diabetes during the second trimester, but some women are at high risk and could benefit from earlier intervention.

“Our study leveraged artificial intelligence to predict gestational diabetes in the first trimester using electronic health record data from a Chinese hospital,” says study author He-Feng Huang, PhD, of the Shanghai Jiao Tong University School of Medicine and the International Peace Maternity and Child Health Hospital in Shanghai, China. “These findings can help clinicians identify women at high risk of diabetes in early pregnancy and start interventions such as diet changes sooner. The artificial intelligence technology will continue to improve over time and help us better understand the risk factors for gestational diabetes.”

The researchers analyzed nearly 17,000 electronic health records from a hospital in China in 2017 with machine learning models to predict women at high risk for gestational diabetes. They compared their predictions with 2018 electronic health record data and found they were successful at identifying who would develop gestational diabetes. The prediction models also found an association between low body mass and gestational diabetes.

Endocrinology and Metabolism: Open Access is a peer reviewed journal which focuses on the publication of current research and developments on the endocrine glands and its secretions with their coordination with metabolism and reproduction.

Endocrinology and Metabolism: Open Access aims to function as the global face of endocrinology research. The journal accepts manuscripts in the form of original research article, review article, short communication, case report, letter-to-the-Editor and Editorials for publication in an open access platform. All the articles published in the journal can be accessed online without any subscription charges and will receive the benefit of extensive worldwide visibility.

Journal is now accepting manuscripts for volume 5 issue 1 for year 2021. We publish minimum of 5 and maximum of 20 articles per issue. Submissions to our journal are given high priority during the process.

Submit your manuscript at: https://www.imedpub.com/submissions/endocrinology-metabolism-open-access.html 

Send as an attachment to mail endometabol@emedscholar.com

Media Contact
Eliza Grace
Associate Managing Editor
Endocrinology and Metabolism: Open Access
E-Mail: endometabol@emedscholar.com